Aug 15, 2020 In this week’s “From Academia“, we share with you two review articles exploring bioprinting for a better understanding of cancer biology and Immersive realities, including Augmented Reality (AR), Mixed Reality (MR), and Virtual Reality (VR) for congenital heart disease applications. The third article focuses on using their novel ultrathin probe fabrication technique that utilizes 3D microprinting to fabricate a fully functional ultrathin aberration-corrected optical coherence tomography probe, enabling future development of novel minimally invasive characterization techniques of diseases.
“From Academia” features recent, relevant, close to commercialization academic publications. Subjects include but not limited to healthcare 3D printing, 3D bioprinting, and related emerging technologies.
Email: Rance Tino (info@3dheals.com) if you want to share relevant academic publications with us.
3D bioprinting for reconstituting the cancer microenvironment
Authored by Pallab Datta, Madhuri Dey, Zaman Ataie, Derya Unutmaz & Ibrahim T. Ozbolat. Nature npj Precision Oncology, 27 July 2020
Advanced Medical Use of Three-Dimensional Imaging in Congenital Heart Disease: Augmented Reality, Mixed Reality, Virtual Reality, and Three-Dimensional Printing
Authored by Hyun Woo Goo, Sang Joon Park, and Shi-Joon Yoo. Korean Journal of Radiology. 8 January 2020.
Ultrathin monolithic 3D printed optical coherence tomography endoscopy for preclinical and clinical use
Authored by Jiawen Li, Simon Thiele, Bryden C. Quirk, Rodney W. Kirk, Johan W. Verjans, Emma Akers, Christina A. Bursill, Stephen J. Nicholls, Alois M. Herkommer, Harald Giessen & Robert A. McLaughlin. Nature Light: Science & Applications, 20 July 2020
Related Articles:
From Academia: 3D Bioprined Dendritic Vascular Networks, Cornea, Alternative Drug Delivery
From Academia: Mixed Reality, Augmented Reality, and 3D Printing in Healthcare
Comments